From my article on MDEdge, by Larry Robbins, M.D. Editors’ note: For the April edition of Expert Perspectives, we asked two leading neurologists to present differing views on the use of calcitonin gene-related peptide (CGRPs) monoclonal antibodies (mAbs) for the treatment of migraine. Here, Larry Robbins, MD, of the Robbins Headache Clinic in Riverwoods, IL, discusses … Continue reading CGRP Migraine Monoclonal Injections: proceed with caution” from Dr. Robbins, M.D.